Skip to main content
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · IEX Real-Time Price · USD
0.860
+0.082 (10.60%)
At close: Apr 26, 2024, 4:00 PM
0.856
-0.005 (-0.53%)
After-hours: Apr 26, 2024, 7:59 PM EDT

Ginkgo Bioworks Holdings Revenue

In the year 2023, Ginkgo Bioworks Holdings had annual revenue of $251.46M, a decrease of -47.36%. Revenue in the quarter ending December 31, 2023 was $34.76M, a -64.64% decrease year-over-year.

Revenue (ttm)
$251.46M
Revenue Growth
-47.36%
P/S Ratio
7.35
Revenue / Employee
$206,449
Employees
1,218
Market Cap
1.85B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023251.46M-226.25M-47.36%
Dec 31, 2022477.71M163.87M52.21%
Dec 31, 2021313.84M237.18M309.40%
Dec 31, 202076.66M22.47M41.48%
Dec 31, 201954.18M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Owens & Minor 10.33B
BrightSpring Health Services 8.83B
Amneal Pharmaceuticals 2.39B
NeoGenomics 591.64M
Galapagos NV 266.36M
Recursion Pharmaceuticals 44.58M
Avidity Biosciences 9.56M
Fusion Pharmaceuticals 2.07M
Revenue Rankings

DNA News

More News